GIP and obesity disorder: Tirzepatide is a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist for management of obesity and blood sugar levels in adults with type 2 diabetes; however, its impacts on alopecia are unknown.